ATE359819T1 - Rekombinante oder gereinigte polyklonale antikörper zur behandlung den allergien - Google Patents

Rekombinante oder gereinigte polyklonale antikörper zur behandlung den allergien

Info

Publication number
ATE359819T1
ATE359819T1 AT01936042T AT01936042T ATE359819T1 AT E359819 T1 ATE359819 T1 AT E359819T1 AT 01936042 T AT01936042 T AT 01936042T AT 01936042 T AT01936042 T AT 01936042T AT E359819 T1 ATE359819 T1 AT E359819T1
Authority
AT
Austria
Prior art keywords
grass
allergen
pollen
polyclonal antibody
recombinant
Prior art date
Application number
AT01936042T
Other languages
English (en)
Inventor
John S Haurum
Kirsten Drejer
Ulrik Gregers Winther Moerch
Original Assignee
Symphogen As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Symphogen As filed Critical Symphogen As
Application granted granted Critical
Publication of ATE359819T1 publication Critical patent/ATE359819T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/14—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from fungi, algea or lichens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/16—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from plants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
AT01936042T 2000-05-26 2001-05-25 Rekombinante oder gereinigte polyklonale antikörper zur behandlung den allergien ATE359819T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200000839 2000-05-26
US21198100P 2000-06-16 2000-06-16

Publications (1)

Publication Number Publication Date
ATE359819T1 true ATE359819T1 (de) 2007-05-15

Family

ID=26068829

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01936042T ATE359819T1 (de) 2000-05-26 2001-05-25 Rekombinante oder gereinigte polyklonale antikörper zur behandlung den allergien

Country Status (13)

Country Link
EP (1) EP1283720B1 (de)
JP (1) JP2003534290A (de)
KR (1) KR100831118B1 (de)
CN (1) CN1437482A (de)
AT (1) ATE359819T1 (de)
AU (2) AU6206701A (de)
CA (1) CA2410586C (de)
DE (1) DE60127954T2 (de)
DK (1) DK1283720T3 (de)
ES (1) ES2282256T3 (de)
HK (1) HK1052305B (de)
NZ (1) NZ522605A (de)
WO (1) WO2001089563A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2467032A1 (en) * 2001-11-13 2003-05-22 Vlaams Interuniversitair Instituut Voor Biotechnologie Vzw Method to obtain protection against bystander allergen
CN100383244C (zh) * 2003-01-07 2008-04-23 西福根有限公司 用于生产重组多克隆蛋白质的方法
KR101024443B1 (ko) * 2003-01-07 2011-03-23 심포젠 에이/에스 재조합 폴리클로날 단백질의 제조 방법
TWI333977B (en) * 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
JP2007537288A (ja) 2004-05-12 2007-12-20 バクスター インターナショナル インコーポレイテッド オリゴヌクレオチド含有マイクロスフェア、１型糖尿病を処置する医薬の製造のための、その使用
AU2005244842B2 (en) 2004-05-12 2010-09-23 Baxter Healthcare S.A. Nucleic acid microspheres, production and delivery thereof
US8728525B2 (en) 2004-05-12 2014-05-20 Baxter International Inc. Protein microspheres retaining pharmacokinetic and pharmacodynamic properties
CN103393601A (zh) 2004-05-12 2013-11-20 巴克斯特国际公司 含有蛋白并在高浓度蛋白下显示可注射性的微球体
BRPI0513706A (pt) 2004-07-20 2008-05-13 Symphogen As anticorpo policlonal recombinante anti-rhesus d e métodos de produção
WO2006007853A2 (en) 2004-07-20 2006-01-26 Symphogen A/S A procedure for structural characterization of a recombinant polyclonal protein or a polyclonal cell line
CN101500616A (zh) 2006-08-04 2009-08-05 巴克斯特国际公司 预防和/或逆转新发作自身免疫糖尿病的基于微球的组合物
TW200846362A (en) * 2007-02-09 2008-12-01 Symphogen As A polyclonal antibody product
ATE521704T1 (de) 2007-03-01 2011-09-15 Symphogen As Verfahren zur klonierung verwandter antikörper
JP5744513B2 (ja) 2007-04-17 2015-07-08 バクスター・インターナショナル・インコーポレイテッドＢａｘｔｅｒ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｉｎｃｏｒｐ０Ｒａｔｅｄ 肺送達のための核酸微小粒子
SG189793A1 (en) * 2008-04-23 2013-05-31 Symphogen As Methods for manufacturing a polyclonal protein
KR101242797B1 (ko) * 2010-06-08 2013-03-12 아주대학교산학협력단 락토페린 발현 수준 측정 제재를 포함하는 알러지성 비염 진단용 조성물
KR101803187B1 (ko) 2015-05-20 2017-12-01 중앙대학교 산학협력단 돼지풀 추출물을 유효성분으로 함유하는 IL-1β 관련질환 예방 또는 치료용 약학조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
US4740371A (en) * 1984-09-17 1988-04-26 International Institute Of Cellular And Molecular Pathology Treatment of allergy
CA1336818C (en) * 1987-04-16 1995-08-29 International Institute Of Cellular And Molecular Pathology Treatment of allergy and composition thereof
US5512283A (en) * 1990-07-06 1996-04-30 Allergene, Inc. Methods for the selective suppression of an immune response to dust mite der Pi
JPH08501799A (ja) * 1992-12-21 1996-02-27 タノックス バイオシステムズ インコーポレイテッド アレルゲン特異的ＩｇＡモノクローナル抗体及びアレルギー治療のための関連物質
EP1231268B1 (de) * 1994-01-31 2005-07-27 Trustees Of Boston University Bibliotheken aus Polyklonalen Antikörpern
ATE435023T1 (de) * 1996-09-11 2009-07-15 Elizabeth Shanahan-Prendergast Therapeutische formulierungen, die schlangen- und/oder insektengift enthalten, zur prophylaxe und therapie von neoplasmen

Also Published As

Publication number Publication date
NZ522605A (en) 2005-03-24
CA2410586A1 (en) 2001-11-29
CN1437482A (zh) 2003-08-20
AU6206701A (en) 2001-12-03
AU2001262067B2 (en) 2005-09-29
JP2003534290A (ja) 2003-11-18
DK1283720T3 (da) 2007-08-13
HK1052305B (zh) 2007-10-12
KR100831118B1 (ko) 2008-05-20
WO2001089563A1 (en) 2001-11-29
HK1052305A1 (en) 2003-09-11
KR20030022134A (ko) 2003-03-15
DE60127954T2 (de) 2008-01-17
DE60127954D1 (de) 2007-05-31
EP1283720A1 (de) 2003-02-19
EP1283720B1 (de) 2007-04-18
ES2282256T3 (es) 2007-10-16
CA2410586C (en) 2010-07-20

Similar Documents

Publication Publication Date Title
ATE359819T1 (de) Rekombinante oder gereinigte polyklonale antikörper zur behandlung den allergien
Flicker et al. Renaissance of the blocking antibody concept in type I allergy
Rumold et al. Secondhand smoke induces allergic sensitization in mice
Gevaert et al. Organization of secondary lymphoid tissue and local IgE formation to Staphylococcus aureus enterotoxins in nasal polyp tissue
Choi et al. Bee pollen-induced anaphylaxis: a case report and literature review
Flicker et al. Passive immunization with allergen-specific IgG antibodies for treatment and prevention of allergy
ATE499112T1 (de) Immunologische verwendungen von immunmodulatorischen verbindungen für einen impfstoff und therapie gegen infektionskrankheiten
Jaligama et al. Regulatory T cells and IL10 suppress pulmonary host defense during early-life exposure to radical containing combustion derived ultrafine particulate matter
WO2002005630A3 (en) Drug delivery device for animals
IL312710A (en) Methods for treating allergy and improving allergen-specific immunotherapy by administering an IL-4R inhibitor
PH12012501089A1 (en) Therapeutic human anti-il-1r1 monoclonal antibody
DE69636278D1 (de) Inhibitor des muskelproteinabbaus enthaltend einen il-6 rezeptor antikörper
ATE181575T1 (de) Rekombinierte humane antikörper gegen den humanen interleukin 6-rezeptor
NO970108L (no) Konjugat mellom et modifisert superantigen og en målsökende forbindelse samt anvendelse av konjugatet
Qin et al. The clinical significance of allergen-specific IgG4 in allergic diseases
Masuyama et al. Guiding principles of sublingual immunotherapy for allergic rhinitis in Japanese patients
WO2021195385A8 (en) HUMAN MONOCLONAL ANTIBODIES TO SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS 2 (SARS-CoV-2)
Van Regenmortel et al. Immunochemical studies of tobacco mosaic virus—II: Univalent and monogamous bivalent binding of IgG antibody
Reginald et al. Different modes of IgE binding to CD23 revealed with major birch allergen, Bet v 1‐specific monoclonal IgE
DE69636527D1 (de) Antigenes protein aus malassezia
Huang et al. Induction of specific Th1 responses and suppression of IgE antibody formation by vaccination with plasmid DNA encoding Cyn d 1
ATE435032T1 (de) Impstoff gegen yersinia mit einem oder zwei monoklonaler antikörper, die für yersinia pestis f1-antigen und v-antigen spezifisch sind
SE9703531D0 (sv) Non-anaphlactic forms of allergens and their use
ATE290081T1 (de) Parietaria judaica ns-ltp-antigenvarianten, entsprechende pharmazeutische zusammensetzungen und ihre verwendung
Kernerman et al. 196 Evidence of cross-reactivity between olive, ash, privet, and Russian olive tree pollens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1283720

Country of ref document: EP

REN Ceased due to non-payment of the annual fee